Aspirin and percutaneous coronary angioplasty are associated with a decline in mortality from cardiogenic shock: Results from a National Israeli Survey, 1992-1998

Cardiology

Volumn 95, Issue 3, 2001, Pages 119-125

  Barbash, Israel M ^a   Battler, Alexander ^b   Behar, Solomon ^c   Boyko, Valentina ^c   Gottlieb, Shmuel ^c   Hasdai, David ^b   Leor, Jonathan ^a,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Angioplasty; Cardiogenic shock; Heart failure; Myocardial infarction; Transluminal percutaneous coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY DILATATION; COUNTERPULSATION; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; FEMALE; HEALTH SURVEYS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTRA-AORTIC BALLOON PUMPING; ISRAEL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 0034901527     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047357     Document Type: Article

References (18)

1. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease. 1987-1994
2. Population-wide mortality trends among patients hospitalized for acute myocardial infarction: The Ontario experience. 1981 to 1991
3. Temporal trends in cardiogenic shock complicating acute myocardial infarction
4. Trends in cardiogenic shock: Report from the SHOCK trial registry
5. Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries
6. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial
7. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era
8. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: Results from the GUSTO trial
9. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry
10. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH
11. Cardiogenic shock
12. Early revascularization in acute myocardial infarction complicated by cardiogenic shock
13. Improved outcome of elderly patients (≥ 75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel
14. Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
15. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: The second National Registry of Myocardial Infarction
16. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation
17. Do 'America's Best Hospitals' perform better for acute myocardial infarction?